Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company dedicated to accelerating the development of bio-medicine and significantly reducing manufacturing costs. Their core strengths are molecular design, process design, drug product design and manufacturing plant design.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 6, 2018 | Series B | $35M | 3 | — | — | Detail |
Aug 8, 2017 | Series B | ¥400M | 2 | — | — | Detail |
Jul 25, 2016 | Series A | $14M | 3 | — | — | Detail |
Sep 21, 2015 | Series A | $15M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series B |
BOCGI Zheshang Capital | — | Series B |
Lilly Asia Ventures | — | Series B |
Merck | — | Series A |